Market Place
Sourcing Support
NeoGenomics Launches RaDaR ST for Solid Tumors Type
25 Feb 2026 //
PHARMIWEB
NeoGenomics Reports Fourth Quarter And Full Year 2025 Results
17 Feb 2026 //
PHARMIWEB
NeoGenomics Launches PanTracer Pro For Solid Tumor Therapy
12 Feb 2026 //
PHARMIWEB
NeoGenomics To Release Q4 And Full Year 2025 Financial Results
27 Jan 2026 //
BUSINESSWIRE
Neogenomics To Present New Ctdna Research At SABCS 2025
10 Dec 2025 //
BUSINESSWIRE
NeoGenomics Presents CGP Study on Myeloid Malignancies at ASH
08 Dec 2025 //
PHARMIWEB
NeoGenomics to Present RaDaR ST MRD Study at ISLB 2025
30 Oct 2025 //
BUSINESSWIRE
Neogenomics To Highlight Radar ST MRD Assay At ESMO Congress 2025
14 Oct 2025 //
PHARMIWEB
Neogenomics To Release Q3 2025 Financial Results On October 28
07 Oct 2025 //
PHARMIWEB
NeoGenomics to Report Q2 2025 Financial Results on July 29
01 Jul 2025 //
BUSINESSWIRE
NeoGenomics Appoints Dr. Marjorie Green to Board of Directors
24 Jun 2025 //
BUSINESSWIRE
NeoGenomics Introduces PanTracer Genomic Tests at ASCO 2025
28 May 2025 //
BUSINESSWIRE
NeoGenomics to Present PanTracer LBx Study at AACR Meeting
22 Apr 2025 //
BUSINESSWIRE
NeoGenomics Completes Acquisition of Pathline
07 Apr 2025 //
BUSINESSWIRE
NeoGenomics Expands Oncology Testing With Pathline Acquisition
10 Mar 2025 //
BUSINESSWIRE
NeoGenomics to Participate in Upcoming Investor Conferences
24 Feb 2025 //
BUSINESSWIRE
NeoGenomics to Report Q4 & Full Year Financial Results on Feb 18
29 Jan 2025 //
BUSINESSWIRE
Adaptive Bio & NeoGenomics Expand Cancer Disease Monitoring Access
14 Jan 2025 //
GLOBENEWSWIRE
NeoGenomics to Present Research on Hematologic Malignancies at ASH
09 Dec 2024 //
BUSINESSWIRE
NeoGenomics at Piper Sandler 36th Healthcare Conference
08 Nov 2024 //
BUSINESSWIRE
NeoGenomics Reports Q32024 Results
05 Nov 2024 //
BUSINESSWIRE
NeoGenomics to Report Q3 2024 Financial Results on Nov. 5, 2024
15 Oct 2024 //
BUSINESSWIRE
NeoGenomics Launches AML Express For Rapid Genetic Profiling
08 Oct 2024 //
BUSINESSWIRE
NeoGenomics Announces New RaDaR Technology Litigation Resolved
23 Sep 2024 //
BUSINESSWIRE
NeoGenomics To Present New Cancer Diagnostics Data At ESMO 2024
11 Sep 2024 //
BUSINESSWIRE
NeoGenomics To Participate In Morgan Stanley Healthcare Conference
29 Aug 2024 //
BUSINESSWIRE
NeoGenomics: Lung Solution, Hematopathology Services Insights At ASCO
28 May 2024 //
BUSINESSWIRE
NeoGenomics Reports First Quarter 2024 Results
30 Apr 2024 //
BUSINESSWIRE
NeoGenomics Showcases Commitment to Transforming Cancer Patient Care at Meeting
27 Mar 2024 //
BUSINESSWIRE
NeoGenomics to Participate in the TD Cowen 44th Annual Health Care Conference
01 Mar 2024 //
BUSINESSWIRE
NeoGenomics Reports Fourth Quarter and Full Year 2023 Results
20 Feb 2024 //
BUSINESSWIRE
NeoGenomics Signs Working with Cancer Pledge in Support of Employees
01 Feb 2024 //
BUSINESSWIRE
NeoGenomics to Report Fourth Quarter and Full Year 2023 Financial Results
30 Jan 2024 //
BUSINESSWIRE
NeoGenomics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
02 Jan 2024 //
BUSINESSWIRE
NeoGenomics to Appeal Ruling
28 Dec 2023 //
ACCESSWIRE
NeoGenomics to Participate at Piper Sandler 35th Annual Healthcare Conference
14 Nov 2023 //
ACCESSWIRE
NeoGenomics Reports Third Quarter 2023 Results
06 Nov 2023 //
ACCESSWIRE
NeoGenomics Announces the Commercial Availability of Two New Tests
24 Oct 2023 //
ACCESSWIRE
NeoGenomics to Report Third Quarter 2023 Financial Results on November 6, 2023
17 Oct 2023 //
ACCESSWIRE
NeoGenomics Announces Medicare Coverage for RaDaR Assay
27 Jul 2023 //
ACCESSWIRE
NeoGenomics to Report Second Quarter 2023 Financial Results on August 8, 2023
18 Jul 2023 //
ACCESSWIRE
NeoGenomics Expands BOD with Appointments of Three Independent Directors
29 Jun 2023 //
ACCESSWIRE
NeoGenomics` RaDaR Assay for imal Residual Disease Receives Commercial Coverage
15 Jun 2023 //
ACCESSWIRE
NeoGenomics & Breast Group Announce Data Showing Potential of RaDaR MRD Assay
05 Jun 2023 //
ACCESSWIRE
NeoGenomics to Participate at Goldman Sachs 44th Healthcare Conference
01 Jun 2023 //
ACCESSWIRE
NeoGenomics to Showcase the Transformational Impact of RaDaR(R) Assay at ASCO
30 May 2023 //
ACCESSWIRE
NeoGenomics to Announce First Quarter 2023 Financial Results
17 Apr 2023 //
ACCESSWIRE
NeoGenomics to Participate at 22nd Annual Needham Virtual Healthcare Conference
11 Apr 2023 //
ACCESSWIRE
NeoGenomics to Share Nine Abstracts at AACR Annual Meeting 2023
06 Apr 2023 //
ACCESSWIRE
NeoGenomics to Host Investor Day on April 4, 2023
27 Mar 2023 //
ACCESSWIRE
